Yunqi Capital Backs Zhudong Technology to Advance Brain-Computer Interface Clinical Applications | Yunqi Partners
Sets Record for Brain-Computer Interface Angel+ Round
Sets Record for Brain-Computer Interface Angel+ Round
"In the 21st century, things are God, and people are tools."
Every precious fragment of human experience.
Recently, Dalton Venture portfolio company Zhudong Technology announced the completion of a 4.
Recently, **Dalton Venture portfolio company Shuimu Molecule Biotechnology Co., Ltd. (hereinafter referred to as "Shuimu Molecule")** emerged from 1,200 applicants worldwide in the "**2026 Win in AI+**" entrepreneurship gala, co-hosted by China Media Group and the Hangzhou Municipal Government. After multiple rounds of competition, it **was named one of the "Top Ten AI Visionaries" — the only AI drug discovery company on the list**.
Deepening Full-Stack R&D to Advance Brain-Computer Interfaces Toward Clinical Application
Got greedy this time.
Focused on developing foundational computing chips for multimodal large models, including intelligent video and generative video applications.
From models and compute to delivery and applications, here's how MaHui members are building their capabilities into integrated systems.
Celebrating milestone moments with Qiming Venture Partners portfolio companies